Japan Radiopharmaceuticals Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Radiopharmaceuticals market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Radiopharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by Radiopharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Novartis (AAA)

    • Navidea

    • SIEMENS

    • IBA Group

    • Mallinckrodt

    • PeptiDream

    • Lantheus Medical Imaging

    • Nordion

    • Eli Lilly

    • Bayer

    • Triad Isotopes

    • Lantheus


    By Type:

    • Therapeutic Radioisotopes

    • Diagnostic Radioisotopes


    By End-User:

    • Cardiology

    • Oncology

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Radiopharmaceuticals Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

      • 1.3.2 Japan Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2014 to 2026

      • 1.4.2 Japan Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.3 Japan Radiopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Radiopharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Radiopharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Therapeutic Radioisotopes

      • 3.4.2 Market Size and Growth Rate of Diagnostic Radioisotopes


    4 Segmentation of Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Radiopharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Radiopharmaceuticals in Cardiology

      • 4.4.2 Market Size and Growth Rate of Radiopharmaceuticals in Oncology

      • 4.4.3 Market Size and Growth Rate of Radiopharmaceuticals in Others


    5 Market Analysis by Regions

    • 5.1 Japan Radiopharmaceuticals Production Analysis by Regions

    • 5.2 Japan Radiopharmaceuticals Consumption Analysis by Regions


    6 Hokkaido Radiopharmaceuticals Landscape Analysis

    • 6.1 Hokkaido Radiopharmaceuticals Landscape Analysis by Major Types

    • 6.2 Hokkaido Radiopharmaceuticals Landscape Analysis by Major End-Users


    7 Tohoku Radiopharmaceuticals Landscape Analysis

    • 7.1 Tohoku Radiopharmaceuticals Landscape Analysis by Major Types

    • 7.2 Tohoku Radiopharmaceuticals Landscape Analysis by Major End-Users


    8 Kanto Radiopharmaceuticals Landscape Analysis

    • 8.1 Kanto Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 Kanto Radiopharmaceuticals Landscape Analysis by Major End-Users


    9 Chubu Radiopharmaceuticals Landscape Analysis

    • 9.1 Chubu Radiopharmaceuticals Landscape Analysis by Major Types

    • 9.2 Chubu Radiopharmaceuticals Landscape Analysis by Major End-Users


    10 Kinki Radiopharmaceuticals Landscape Analysis

    • 10.1 Kinki Radiopharmaceuticals Landscape Analysis by Major Types

    • 10.2 Kinki Radiopharmaceuticals Landscape Analysis by Major End-Users


    11 Chugoku Radiopharmaceuticals Landscape Analysis

    • 11.1 Chugoku Radiopharmaceuticals Landscape Analysis by Major Types

    • 11.2 Chugoku Radiopharmaceuticals Landscape Analysis by Major End-Users


    12 Shikoku Radiopharmaceuticals Landscape Analysis

    • 12.1 Shikoku Radiopharmaceuticals Landscape Analysis by Major Types

    • 12.2 Shikoku Radiopharmaceuticals Landscape Analysis by Major End-Users


    13 Kyushu Radiopharmaceuticals Landscape Analysis

    • 13.1 Kyushu Radiopharmaceuticals Landscape Analysis by Major Types

    • 13.2 Kyushu Radiopharmaceuticals Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Novartis (AAA)

      • 14.1.1 Novartis (AAA) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Navidea

      • 14.2.1 Navidea Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 SIEMENS

      • 14.3.1 SIEMENS Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 IBA Group

      • 14.4.1 IBA Group Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Mallinckrodt

      • 14.5.1 Mallinckrodt Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 PeptiDream

      • 14.6.1 PeptiDream Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Lantheus Medical Imaging

      • 14.7.1 Lantheus Medical Imaging Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Nordion

      • 14.8.1 Nordion Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Eli Lilly

      • 14.9.1 Eli Lilly Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Bayer

      • 14.10.1 Bayer Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Triad Isotopes

      • 14.11.1 Triad Isotopes Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Lantheus

      • 14.12.1 Lantheus Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 126 Figures and 155 Tables)

     

    • Figure Japan Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • Figure Japan Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Radiopharmaceuticals by Different Types from 2014 to 2026

    • Table Consumption Share of Radiopharmaceuticals by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Therapeutic Radioisotopes

    • Figure Market Size and Growth Rate of Diagnostic Radioisotopes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Table Consumption Share of Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Figure Japan Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Radiopharmaceuticals Production by Regions

    • Table Japan Radiopharmaceuticals Production Share by Regions

    • Figure Japan Radiopharmaceuticals Production Share by Regions in 2014

    • Figure Japan Radiopharmaceuticals Production Share by Regions in 2018

    • Figure Japan Radiopharmaceuticals Production Share by Regions in 2026

    • Table Japan Radiopharmaceuticals Consumption by Regions

    • Table Japan Radiopharmaceuticals Consumption Share by Regions

    • Figure Japan Radiopharmaceuticals Consumption Share by Regions in 2014

    • Figure Japan Radiopharmaceuticals Consumption Share by Regions in 2018

    • Figure Japan Radiopharmaceuticals Consumption Share by Regions in 2026

    • Table Hokkaido Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Hokkaido Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Hokkaido Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Hokkaido Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Hokkaido Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Hokkaido Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Hokkaido Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Tohoku Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Tohoku Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Tohoku Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Tohoku Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Tohoku Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Tohoku Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Tohoku Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Tohoku Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kanto Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kanto Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kanto Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kanto Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kanto Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kanto Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kanto Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kanto Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Chubu Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Chubu Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Chubu Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Chubu Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Chubu Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Chubu Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Chubu Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Chubu Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kinki Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kinki Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kinki Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kinki Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kinki Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kinki Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kinki Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kinki Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Chugoku Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Chugoku Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Chugoku Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Chugoku Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Chugoku Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Chugoku Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Chugoku Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Chugoku Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Shikoku Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Shikoku Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Shikoku Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Shikoku Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Shikoku Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Shikoku Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Shikoku Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Shikoku Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kyushu Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kyushu Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kyushu Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kyushu Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kyushu Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kyushu Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kyushu Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kyushu Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Novartis (AAA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis (AAA)

    • Figure Sales and Growth Rate Analysis of Novartis (AAA)

    • Figure Revenue and Market Share Analysis of Novartis (AAA)

    • Table Product and Service Introduction of Novartis (AAA)

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of PeptiDream

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PeptiDream

    • Figure Sales and Growth Rate Analysis of PeptiDream

    • Figure Revenue and Market Share Analysis of PeptiDream

    • Table Product and Service Introduction of PeptiDream

    • Table Company Profile and Development Status of Lantheus Medical Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus Medical Imaging

    • Figure Sales and Growth Rate Analysis of Lantheus Medical Imaging

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging

    • Table Product and Service Introduction of Lantheus Medical Imaging

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.